Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.arcmed.2020.10.010

http://scihub22266oqcxt.onion/10.1016/j.arcmed.2020.10.010
suck pdf from google scholar
33070986!7547601!33070986
unlimited free pdf from europmc33070986    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33070986      Arch+Med+Res 2021 ; 52 (1): 123-126
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19: Clouds Over the Antimicrobial Resistance Landscape #MMPMID33070986
  • Rodriguez-Alvarez M; Lopez-Vidal Y; Soto-Hernandez JL; Miranda-Novales MG; Flores-Moreno K; Ponce de Leon-Rosales S
  • Arch Med Res 2021[Jan]; 52 (1): 123-126 PMID33070986show ga
  • In recent years, the increase in antimicrobial resistance (AMR) has been recognized as a real threat to human and animal health. It is a problem that has been given the highest priority, uniting nations in the fight against its causes and effects. Among the actions that have been implemented are: clinical and microbiological surveillance, promotion of rational and controlled use of antibiotics, AMR stewardship programs in hospitals, development of tools for rapid diagnosis of infectious diseases to establish prompt and adequate treatment, and radically improving vaccination strategies. The current COVID-19 pandemic has placed disproportionate demands on the healthcare infrastructure and economy worldwide, which will negatively impact on the availability of materials as well as the technical capacity for diagnosis, patient care, and treatment of both COVID-19 and non-COVID-19 patients. Disruptions to production and distribution chains will hamper the availability and usage of antibiotics, also interrupting several of the activities that have been implemented thus far to combat AMR, including detailed laboratory monitoring and reinforced vaccination programs. Here, we discuss the main aspects that should be considered with regard to AMR, that may be affected by the pandemic and propose some actions to counter them.
  • |*COVID-19 Drug Treatment[MESH]
  • |*Drug Resistance, Bacterial[MESH]
  • |Animals[MESH]
  • |Anti-Bacterial Agents/*administration & dosage[MESH]
  • |COVID-19/*epidemiology/microbiology[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box